INSERM
Evotec Strikes Metabolic Disease Research Alliance With Inserm, Lille University Hospital
Evotec will use samples from an ongoing clinical trial of obesity to generate omics data that can provide insights into the etiology of various metabolic diseases.
Investigators from Inserm and Radboud University Medical Center are spearheading the endeavor, called HT-Advance, which is funded by the EU, the UK, and Switzerland.
Researchers have identified immune cell gene expression signatures that could one day be developed into tests to predict response to treatment.
Presence of B Cells in Tumors Associated With Favorable Immunotherapy Outcomes
Three new studies have found that the presence of B cells in tertiary lymphoid structures in tumors is associated with a favorable response to immunotherapy.